Novel lipid metabolism factor HIBCH inhibitor synergizes with doxorubicin to suppress osteosarcoma growth and impacts clinical prognosis in osteosarcoma patients
新型脂质代谢因子HIBCH抑制剂与阿霉素协同作用,抑制骨肉瘤生长,并影响骨肉瘤患者的临床预后。
期刊:Journal of Bone Oncology
影响因子:3.5
doi:10.1016/j.jbo.2024.100652
Yuan, Xuhui; Yu, Bo; Ding, Haiqi; Li, Hongyan; Wang, Qijing; Lin, Lan; Zhang, Wenming; Fang, Xinyu